Lp(a) was once again the focus of multiple presentations at the National Lipid Association Annual Scientific Sessions (Las Vegas, USA, 30 May-2 June 2024), with the emphasis on raising awareness about the importance of Lp(a) as a major risk factor for atherosclerotic cardiovascular disease and the need to change attitudes and break down barriers to Lp(a) testing.
Read the reports:
